Considering the antiproliferative effect of the mTOR inhibitors [12] and expression of mTOR in UIP lungs, mTOR inhibitor may be a potential therapeutic drug for the treatment of IPF. Here, MTOR is linked to idiopathic pulmonary fibrosis.